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Background: Minimal-access video-assisted thyroidectomy (MIVAT) has now become a widespread
technique in the treatment of benign thyroid disease. No studies systematically investigate risk factors
for postoperative complications. The aim of our study was to investigate possible risk factors for post-
operative complications in MIVAT in patients with benign disease. Methods: One-hundred eighty-nine
patients who underwent MIVAT for benign disease were retrospectively identiﬁed in a prospectively-
maintained institutional register of thyroid surgery. Exclusion criteria were: (1) thyroid
volume>45 mL; (2) malignant disease; (3) prior neck surgery; (4) prior neck irradiation; (5) nodule
size>3 cm; (6) intrathoracic component; (7) follow-up<1 year. Age, sex, comorbidities, body mass index,
existence of symptoms, duration of disease evolution, thyroid volume, hyperthyroidism, thyroiditis, and
the duration of surgery were analyzed as risk factors for complications. We applied both bivariate and
multivariate logistic regression analyses in order to identify risk factors associated with postoperative
complications. Results: Complications were presented by 28 patients (14.8%). The variables associated as
independent risk factors with these complications were hyperthyroidism (OR ¼ 4.31; P ¼ 0.003) and
thyroiditis (OR ¼ 3.59; P ¼ 0.035). Age, sex and thyroid volume up to 45 mL do not seem to be inde-
pendent risk factors. Conclusions: In endocrine surgery units, two independent risk factors for post-
operative complications could be identiﬁed in MIVAT patients: hyperthyroidism and thyroiditis.
Surgeons operating on patients presenting these factors should be aware of the potential augmented risk
in order to correctly adapt intraoperative and postoperative care.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.ection of Endocrine Surgery,
D-79106, Freiburg im Breis-
illmann).
by Elsevier Ltd. All rights reserved1. Introduction
Endoscopic neck surgery was ﬁrst described for para-
thyroidectomy by Gagner in 1996 [1] and subsequently proposed
for thyroid surgery. Six techniques are currently performed: four
complete endoscopic techniques (cervical, axillar, axillo breast
bilateral, and retroauricular access) and two video-assisted.
Table 1
Variables associated with postoperative complications; bivariate analysis.
Variable Complications
(n ¼ 28)
No complications
(n ¼ 161)
P Value
Age, yearsa 38.71 ± 8.98 39.27 ± 7.79 0.732
Sex 0.242
Male (n ¼ 27) 2 25
Female (n ¼ 162) 26 136
Time of evolution, monthsa,b 52.07 ± 19.85 50.04 ± 21.64 0.644
Symptomatic, n (%) 0.153
No (n ¼ 119) 21 (75.0) 98 (60.9)
Yes (n ¼ 70) 7 (25.0) 63 (39.1)
Compressive syndromes, n (%) 0.261
No (n ¼ 182) 28 (100.0) 154 (95.7)
Yes (n ¼ 7) 0 (0.0) 7 (4.3)
Thyroid volume, mLa 34.03 ± 6.22 34.44 ± 7.08 0.753
Hyperthyroidism, n (%) 0.005
No (n ¼ 161) 19 (67.9) 142 (88.2)
Yes (n ¼ 28) 9 (32.1) 19 (11.8)
Associated thyroiditis, n (%) 0.013
No (n ¼ 172) 22 (78.6) 150 (93.2)
Yes (n ¼ 17) 6 (21.4) 11 (6.8)
Extent of Surgery, n (%) 0.451
Hemithyroidectomy 20 (71.4) 105 (65.2)
Thyroidectomy 8 (28.6) 56 (34.8)
Duration of surgery, mina 87.71 ± 22.56 96.96 ± 22.21 0.045
Bold: statistically signiﬁcant P Value.
a Data expressed as Mean ± SD.
b Time from diagnosis to operative therapy.
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technique called MIVAT for minimally-invasive video-assisted
thyroidectomy). Among these techniques, MIVAT has now become
widespread [2e4] and has been described as indicated in selected
patients (e.g. thyroid volume <20e30 mL) [5]. Since Ruggiery
et al. [6], Lai et al. [7], and Fan et al. [8] demonstrated that this
technique can also be performed in patients with a thyroid volume
up to 50 mL and thyroiditis, we extended our inclusion criteria to
patients with a thyroid volume up to 45 mL and thyroiditis. The
advantages of MIVAT are well-documented in several studies for
both benign and malignant disease [4,9e15]. Absolute contraindi-
cations are previous neck surgery, large goiter, local advanced
cancer, and lymph node metastases. Relative contraindications are
hyperthyroidism, thyroiditis [5]. Recently, indications for MIVAT
were extended to include thyroiditis [16]. Minimal-access thyroid
surgery is known to have few therapy-relevant or deﬁnitive com-
plications (eg. injuries to the laryngeal nerve, hematoma, seroma,
hypocalcemia) [9,10,15]. This might be the reason why patients are
concerned about operative complications and the postoperative
cosmetic result [17].
In open procedures, authors have systematically investigated
and described different independent risk factors for postoperative
complications. However, the risk factors for postoperative compli-
cations in minimal-access thyroid surgery and especially MIVAT
have not been systematically investigated. The aims of this study
are to investigate and discuss the independent risk factors associ-
ated with minimal-access thyroidectomy, performed for benign
disease, with special attention to thyroid volume, hyperthyroidism
and thyroiditis.
2. Patients and methods
2.1. Patients
This retrospective study included 189 consecutive patients
identiﬁed in a prospectively-maintained institutional register of
thyroid surgery and surgically treated (with MIVAT) for benign
thyroid disease between June 2010 and April 2012 in our unit for
endocrine surgery. The exclusion criteria were: (1) thyroid
volume > 45 mL; (2) malignant disease; (3) prior neck surgery; (4)
prior neck irradiation; (5) nodule size > 3 cm; (6) intrathoracic
component; (7) follow-up < 1 year.
All patients underwent complete basic blood test and thyroid
hormone activity study, simple chest radiology, and a thyroid so-
nography (Hitachi, Vision), performed by the same ultrasonogra-
pher. Sonography informed in all cases of an eventual intrathoracic
component, and thyroid gland volume data [18e20]. Fine needle
aspiration (FNA) was done if needed (suspicion of malignant dis-
ease, German Guidelines: Leitlinien der Arbeitsgemeinschaft Wis-
senschaftlichen Medizinischen Fachgesellschaften and Leitlinien der
Chirurgischen Arbeitsgemeinschaft Endokrinologie) and enabled
exclusion of patients with suspicious cytology. Laryngoscopy was
preoperatively performed in all patients included.
The operations were performed by 4 surgeons with experience
in endocrine surgery (i.e. they had previously performedmore than
30 MIVAT procedures with the Micolli technique) [2].
2.2. Surgical technique
In summary, a 25e35 mm incision is performed 2 cm above the
sternal notch, the cervical linea alba is divided longitudinally in the
Micolli technique. A small retractor is used to retract the strap
muscles. The upper vessels are selectively ligated by clips and cut
after identiﬁcation of the external branch of the superior laryngeal
nerve. Inferior vessels are also clipped and cut. After lifting thethyroid lobe, the recurrent laryngeal nerve and the parathyroid
glands are dissected from the thyroid. All four parathyroid glands
were not always found. Our policy was to identify at least two
glands in each patient. Well-vascularized glands were left in place,
and devascularized glands were autotransplanted in the musculus
sterno-cleido-mastoideus. The ligament of Berry is then ligated and
cut. The laryngeal recurrent nerve is then checked before division of
the isthmus. This was done using the Dr. Langer Avalanche neu-
romonitoring system in every patient and on each side.
During the immediate postoperative period, we performed
routine determination of calcemia 24 and 48 h after the operation.
A laryngoscopy was performed by an experienced endoscopist in
the ﬁrst postoperative week. Hypoparathyroidism was considered
when the calcium readings were below 7.5 mg/dL or less than
8.5 mg/dL if there were symptoms due to hypocalcemia. Serum
calcium levels remaining below 8.5 mg/dL at 1 year were labeled as
permanent hypocalcemia. We did not order a routine calcium
replacement regime; calcium was administered only if patients
became symptomatic (eg. paresthesia). RLN injury was considered
to be a postoperative alteration in the tone, timbre, or intensity of
the voice, with conﬁrmation of vocal cord alteration by laryngos-
copy; it was deﬁnitive if it persisted more than 12 months.
All patients were reviewed at 1 week, 3 and 6 months and
annually thereafter and were treated with substitutive hormone
therapy if necessary (Levothyroxine). In patients with hypopara-
thyroidism and/or dysphonia, the review was done monthly until
the calcemia returned to normal without medication or the
dysphonia resolved. The patients with RLN injury underwent lar-
yngoscopic control at 6 months, and at 1 year if involvement of the
vocal cord persisted. When ﬁndings were normal in either exami-
nation, the patients returned to standard follow-up.
The variables analyzed to detect risk factors were: (1) age; (2)
sex; (3) comorbidity; (4) body mass index; (5) existence of symp-
toms; (6) duration of evolution; (7) thyroid volume; (8) hyperthy-
roidism; (9) thyroiditis; (10) duration of surgery.
All data were checked for accuracy and analyzed using STATA
12.1 statistical software (StataCorp LP, College Station, TX, USA.) For
statistical analysis, we used a bivariate analysis with a Student t-
test for continuous variables and c2 test for categorial variables; to
F. Billmann et al. / International Journal of Surgery 12 (2014) 1306e13091308determine and evaluate multiple risks, we used logistic regression
analysis using the variables that showed a signiﬁcant association in
the bivariate analysis. P values <0.05 were considered statistically
signiﬁcant.
3. Results
The patients' mean age was 39.2 ± 7.9 years. Most of themwere
women (n ¼ 162, 85.7%), with a mean time of disease evolution
(time from diagnosis to operation) of 50.34 ± 21.35 months. Sixty-
three percent (n ¼ 119) were asymptomatic. In the 5 cases with
hyperthyreosis, there was an increase in T4 and a decrease in TSH.
The mean time of procedure duration was 95.59 ± 22.4 min.
Postoperative, thyroiditis was found by pathological examination in
17 patients (9.0%). The two groups (complication and no compli-
cation groups) were similar in regard to the extent of surgery
(Table 1). Patient demographics are presented in Table 1.
Complications were presented in the postoperative period by 28
patients (14.8%). There were 8 cases of hypoparathyroidism (4.2%)
(all of these patients had returned to normal serum calcium levels
at the 3-month control and calcium and vitamin D3 treatment was
discontinued), 11 RLN injury (5.8%), 6 patients affected on the right
side, 5 on the left side; there was no bilateral injury. Most of the
dysphonias recovered in the ﬁrst 3 months, and the control
laryngoscopy at 6 months showed a return to normality of vocal
cord mobility in almost all patients (one deﬁnitive RLN injury). 3
cervical hematomas (1.6%) and 6 cervical seromas (3.2%) were
diagnosed. No postoperative cervical infections could be noted.
There was no mortality in the perioperative period. The mean
postoperative stay was 2.3 ± 1.7 days.
According to bivariate analysis, the risk factors for development
of a postoperative complication were preoperative hyperthyroid-
ism, associated thyroiditis, and the duration of surgery (Table 1).
According to multivariate analysis, preoperative hyperthyroidism
(OR ¼ 4.31; CI ¼ 1.62e11.51) and associated thyroiditis (OR ¼ 3.59;
CI ¼ 1.09e11.81) remained as independent risk factors (Table 2).
Two patients were lost to follow-up. Neither patient showed any
complication during the ﬁrst postoperative year.
4. Discussion
Minimal-access video-assisted thyroidectomy (usually called by
the acronym MIVAT) can be performed after an appropriate
learning period with minimum deﬁnitive complications (1e25%
depending on series) [18e20]. Although most of the experienced
minimal-access endocrine surgeons hold thyroid volume or hy-
perthyroidism to be risk factors for adverse events in minimal-
access thyroid surgery, there are no studies systematically
analyzing risk factors for postoperative complications in patients
with benign disease.
The overall complication rate in thyroid procedures performed
using the MIVAT technique is approximately 14.8% in our series.
This rate is within the range found in the literature (15%e
30%) [18e22]. Our rate of hypoparathyroidism is 4.2%, with 0.0%
turning out to be deﬁnitive. This rate is also in the range ofTable 2
Variables associated with postoperative complications; multivariate analysis.
Variable Regression
coefﬁcient (b)
Odds ratio
(Conﬁdence intervale)
P Value
Hyperthyroidism 2.92 4.31 (1.62e11.51) 0.003
Thyroiditis 2.10 3.59 (1.09e11.81) 0.035
Duration surgery 1.94 0.97 (0.95e1.00) 0.052
Bold: statistically signiﬁcant P Value.bibliography (1.6%e50.0%) [18e22]. The rate of postoperative RLN
injury was 5.8%, 0.5% turning out to be deﬁnitive. This is in the
upper range of previously-published series (1.0%e9.0%) [21,22].
However, we systematically performed postoperative laryngoscopy
to investigate vocal cord mobility. This is not the case in the ma-
jority of published series, in which laryngoscopy was performed
only in case of clinical symptoms. This can introduce an error in RLN
evaluation, as injuries may be compensated recurrent lesions and
therefore without alteration in the voice [23]. This was also noted
by Rios-Zambudio et al. [22] The present incidence of nerve injuries
is higher than in open techniques, where our surgeons experience
an incidence less than 1.0%. Furthermore, our patients experienced
a total of 3 hematomas and 6 cervical seromas. These ﬁndings were
limited in volume and only 1 hematoma needed operative revision.
As previously demonstrated for open thyroid surgery [24e27],
hyperthyroidism is an independent risk factor in minimal-access
video-assisted thyroidectomy for the development of complica-
tions. Hyperthyroidism leads to gland hypervascularity and this
effect may explain the link to postoperative complications in open
and minimally invasive surgery. Thyroiditis was also identiﬁed in
our study to be an independent risk factor for complications in
MIVAT patients. This factorwas notmentioned by previous authors.
Thyroiditis can lead to adhesions between the thyroid gland and
adjacent structures resulting in greater dissection difﬁculty, espe-
cially in narrow dissection spaces, such as encountered in the
MIVAT technique.
Thyroid volume and an eventual intrathoracic component were
investigated preoperatively using ultrasound examination, which
was demonstrated to be reliable by Miccoli et al. [28], Anderman
et al. [29], Ying et al. [30] and Brauer et al. [31] In open thyroid
surgery, thyroid volume (i.e. thyroid size or weight) was identiﬁed
to be another risk factor for postoperative complications [22,32,33].
Although the majority of authors recommend limiting the use of
MIVAT to thyroid glands up to 30 mL, we extended the indication
up to 45 mL by using a skin incision length up to 35 mm. Surpris-
ingly, preoperative measured thyroid volume (i.e. thyroid gland
volume or weight) was not identiﬁed as an independent risk factor
for complications in our study. For us, this result could be explained
by the clear and magniﬁed views that allow meticulous dissection
of the gland. However, this result could also be linked to a cut-off
effect, volume-related postoperative complications possibly
becoming evident only above 45 mL of thyroid volume. Our series
identiﬁed shorter operative time in our complication group; how-
ever, this factor was not identiﬁed as an independent risk factor for
complications. There was no relevant difference between surgeons
in terms of operative time. Analysis of sex or age in our study could
not conﬁrm results reported in previous works [31,34], which
observe that female sex or advanced age are risk factors.
The speciﬁc multivariate analysis of possible risk factors for the
development of postoperative hypoparathyroidism or post-
operative RLN injuries did not reach statistical signiﬁcance. Thus,
further studies with a larger population are needed, ideally pro-
spective and randomized, to investigate this speciﬁc relationship.
The present study has several limitations: it was retrospective,
limiting its power; furthermore, the limited number of patients did
not allow investigation of the risk factors for each particular
complication (e.g. RLN injury, hypoparathyroidism, hematoma,
seroma). Finally, our series is monocentric and not blinded, a point
which could also be considered a limiting factor.
In conclusion, two independent risk factors for postoperative
complications could be identiﬁed in MIVAT patients: hyperthy-
roidism and thyroiditis. Surgeons operating on patients presenting
these factors should be aware of the potentially augmented risk in
order to correctly adapt intraoperative and postoperative care.
However, we do not think that these factors should be considered
F. Billmann et al. / International Journal of Surgery 12 (2014) 1306e1309 1309as contraindications for MIVAT. Age, sex and thyroid volume were
not identiﬁed as risk factors.
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